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There is a general
sense, and one that
has rung true in
my experience, that
oral abstract pre-
sentations have
been increasingly
poorly attended.ike many of you, I just returned home from the ACC Annual Scientific Sessions
meeting. As in the past, the meeting was outstanding and provided a venue for
important new research findings, state-of-the-art education, information on
ealth policy and legislation, and display of new equipment and technology. It also pro-
ided the opportunity to communicate with colleagues, catch up with friends, and enjoy
few meals that we perhaps would not have indulged in at home. However, one con-
erning aspect of the meeting, as has been true for most large national meetings that I
ave attended recently, was the apparently diminishing role of original research, particu-
arly oral abstract presentations. These presentations seem to be increasingly overshad-
wed by the structured sessions and named lectures in the eyes of both presenters and
udience.
The late-breaking clinical trial (LBCT) sessions again were strongly featured both
rior to and during the sessions. As I have commented in the past (1), these LBCT pre-
entations appear to have taken on a life of their own, and the designation “late-break-
ng” seems to carry an aura of great importance in and of itself. It may be that the ma-
erial covered during the convention is so extensive that these presentations are a
onvenient means to formulate the highlights of the meeting. However, recognizing the
requently immense clinical importance of the large randomized clinical trials, I still be-
ieve that a disproportionate attention is focused on these sessions.
With regard to original research other than LBCTs, the data produce a bit of unease.
he number of abstract submissions reached a maximum of 7,319 in 2001, and has
allen to 5,111 this year. While the number of abstracts accepted increased from 1,622
28%) in 2006 to 2,086 (41%) in 2010, oral abstract presentations have declined from
0% to 9% during the same period. Moreover, the poster sessions, which constitute the
verwhelming majority of accepted submissions, are probably not as well promoted nor
entrally located as they might be. I have witnessed a similar trend to greater poster pre-
entation of research with other societies.
Posters certainly have many advantages relative to oral presentations. Many more
osters than oral abstracts can be accommodated, they are available for a longer duration
f time, and they provide the opportunity for close and detailed interaction of the author
ith interested observers. However, posters often lack the author’s explanation of their
hinking. Moreover, they frequently deprive the observers of hearing the thoughts, ques-
ions, and responses of others, and lack the excitement and tension of having the inves-
igator present and defend the work before a large audience. While posters are clearly
onsidered equivalent to oral presentations, it has been my experience that the majority
f investigators would prefer the latter format.
Why, one may ask, is the vast majority of original research delivered as a poster pre-
entation? There is a general sense, and one that has rung true in my experience, that
ral abstract presentations have been increasingly poorly attended. Reported attendance
t oral abstract sessions has been falling for 7 years at the ACC meeting. Although
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April 20, 2010:1752–3 Editor’s Pageome rooms were overflowing this year, this may have
een related to the size of the rooms. This certainly con-
rasts with the experience I had in attending these meet-
ngs at the onset of my career. Attendees were eager to
earn what was new in their area. Most individuals doing
nvestigation, as well as their mentors, attended the re-
earch presentations. The rooms were generally filled, dis-
ussions were usually spirited and constructive, and those
ttending typically gathered together and interacted dur-
ng the breaks. Most importantly, young investigators
enefitted from the excellent experience and exposure.
Assuming that the premise of poor attendance at oral
essions is correct, and data to substantiate this are diffi-
ult to acquire, the question is why. It may be that there
s a surfeit of new research, but given that JACC received
ver 6,000 submissions last year, that seems unlikely. I do
elieve that the large international conventions have be-
ome increasingly consumed by committee meetings, as-
emblages of research groups, and other such activities,
nd that the mentors and supervisors are increasingly ab-
ent from the research reports. Young investigators follow
heir role models, and if they sense that the research pre-
entations are not most important to them, they are likely
o adopt the same attitude. Moreover, cardiology pro-
rams have become so big that the divisional rehearsals of
he abstracts to be presented, which typically engendered
nterest and enthusiasm, are difficult to organize. The re-
earch sessions might be better featured by the meeting
tself, including focusing greater attention and providing
etter venues. However, the behavior of the program
ommittees is probably the result rather than the cause of
he poor attendance.
It also appears to me that abstracts may have suffered a
oss of value and esteem. A 10-min discourse can provide
nly limited details, and there is no record of what has
een said when the speaker is done. Presentations may
ever become manuscripts, and if they do, they are fre-
uently found to have flaws upon review which prevent
ublication. Even the most highly graded abstracts have a
urprisingly high rejection rate when reviewed as manu-
cripts (2). If, however, rather than being taken as defini-
ive end-products, the abstracts are seen as what they are:
snapshot of the direction that investigation is taking by
hose driving it, a chance to air the work and have it pre-
iewed in preparation for final formulation, and an oppor-
unity for young investigators to exhibit their talent, they
till have enormous value.I must admit to having a personal involvement with
his issue. During my last year of fellowship, when decid-
ng whether to enter practice or remain in academics, I
ad the opportunity to present my first abstract at a na-
ional meeting. I prepared that presentation more than 1
onth prior to the convention, and rehearsed it at least a
ozen times. My paper was scheduled to be delivered at
he last session (Thursday then). The session was held in
cavernous room with a capacity of 500, and was at-
ended by about 30 individuals, primarily the other pre-
enters and their colleagues and relatives. Nevertheless,
y Chairs were luminaries, the audience was knowledge-
ble, I was very nervous, and the whole experience was
xhilarating. The opportunity to make that presentation
ealed my decision to pursue a career in academic medi-
ine. I cannot help but feel that we should provide this
pportunity to as many young investigators as possible.
The large international meetings serve many interest
roups and purposes. As such, a menu of varied content
s to be expected. However, it is important that the content
ot become excessively skewed to specific topics, formats, or
ctivities. I have some concern that we may be in danger
f diminishing the role of original research material, espe-
ially the oral abstract presentations. The reasons for this
eem to be multifactorial, and relate to all the individuals
articipating in the meeting. I believe the time has come
o review the research presentations at the Scientific Ses-
ions and determine what can be done to revitalize them
nd restore that segment of the meeting to its appropriate
tate. Not only would such action be important for the
esearch enterprise, but I believe that it would be one of
he best tools available to attract the next generation of
asic and clinical investigators.
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